Company: ATRA
Filing Date: 2025-03-07
Form Type: 10-K
Source: 0000950170-25-035507
Chunk: 285

Company: Atara Biotherapeutics, Inc.
Filing Date: 2025-03-07
Form: 10-K
Item: Item 8
Chunk 285
---
, and discussions with management. 

•We evaluated the Company’s conclusions related to the accounting for contract modifications. 

•We evaluated management’s determination that the agreements are within the scope of ASC 606 - Revenue from Contracts with Customers. 

•We evaluated management's determination of the contractual term and the appropriateness of management's method to measure its progress over that term. 

•We evaluated the assumptions used in the estimates of total costs and the estimated measure of progress for recognizing revenues by: 

oPerforming corroborating inquiries with the Company's project and business development managers, and comparing the assumptions used in the estimates to management's work plans, cost estimates and costs reported to date, and material rights allocated, accumulated and earned. 

oComparing costs incurred for activities completed to date to the costs forecasted for those activities.

oComparing material rights accumulated and earned for activities completed to date to the fulfilment of performance obligations forecasted for those activities. 

Testing the mathematical accuracy of management’s revenue and current and long-term deferred revenue balances based on the estimated revenue to be recognized over time.

/s/ DELOITTE & TOUCHE LLP

San Francisco, California 

March 7, 2025

We have served as the Company’s auditor since 2013.

98

Atara Biotherapeutics, Inc. 

Consolidated Balance Sheets

(In thousands, except per share amounts)

    December 31,

    December 31,

    2024

    2023

    Assets

    Current assets:

    Cash and cash equivalents
     
    $
    25,030

    $
    25,841

    Short-term investments

    17,466

    25,884

    Restricted cash

    146

    146

    Accounts receivable

    1,482

    34,108

    Inventories

    10,655

    9,706

    Other current assets

    10,115

    6,184

    Total current assets

    64,894

    101,869

    Property and equipment, net

    1,294

    3,856

    Operating lease assets

    39,807

    54,935

    Other assets

    3,103

    4,844

    Total assets
     
    $
    109,098

    $
    165,504

    Liabilities and stockholders’